Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

N/ACompletedNCT02740894

Taipei Veterans General Hospital, Taiwan100 enrolled

Overview

Not significantly increased survival in T/T

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

Interventions

GefitinibDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * NSCLC with spinal metastasis Exclusion Criteria: * brain metastasis and expected survival \< 3 months

Outcomes

Primary Outcomes

Survival and neurologic outcome of 60 participants receiving targeted therapy for nonsmall cell lung cancer with spinal metastaasis. Neurological outcome by Frankel grading and ambulation status.

Time frame: postoperation to mortality, up to 2 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.